Tag
Food and Drug Administration
- Propanc Biopharma skyrockets from pancreatic cancer drug breakthrough
- FDA panel to review GRAIL's Galleri multi-cancer blood test in September
- McMaster surgeon develops AI tool to reduce invasive lung biopsies
- Inovio advances DNA medicine for debilitating respiratory condition
- Guardant Health gets Breakthrough Device Designation from FDA for cancer detection test
- QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics
- Johnson & Johnson subsidiary sued for USD$147M for breaching antitrust rules in California
- Alibaba Group gets FDA nod for cancer detection tool
- Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease
- Median Technologies and European Investment Bank agrees to €37.5M loan
- Breath Diagnostics onboards new president and closes critical financing
- Scholar Rock stock skyrockets on successful phase 3 trial results
- Breath Diagnostics takes aim at lung cancer with One Breath
- FDA publishes first draft guidance document for psychedelics research
- FDA to reject medical device applications without cyberattack protection plans
- Inspira Technologies seeks FDA approval for cardiopulmonary device
- Inspire Medical Systems recruits top tier investor relations talent
- MediPharm Labs to enter US pharmaceutical market via FDA drug registration
- Delta‑8 THC better harm-reduction tool than popular delta‑9 THC, study suggests
- US DEA set to authorize potent pot production for research
- MindMed stock surges on Nasdaq listing approval
- Low‑THC weed led to poor results in major PTSD study
- Charlotte's Web bounces back in Q4
- US FDA unveils plan to gather 'real-world' data to fill CBD research gaps
- Dousing strawberries in CBD oil reduces mould, extends shelf life: study
- FDA's new draft guidelines could speed up CBD drug approvals
- Canopy launches Martha Stewart CBD line in cluttered US market
- Revive Therapeutics approved by FDA for Phase 3 trial of possible Covid‑19 treatment
- Canopy launches CBD website in US despite lack of FDA regulations
- FDA issues cannabis research guidelines as CBD industry still hangs in limbo
- Canopy to launch Martha Stewart CBD brand this fall
- Charlotte's Web backs study on health outcomes of CBD
- Aurora continues winning streak on US CBD deal
- FDA's update on CBD regulations is 'frankly absurd'